Close metadata

Recommended articles:

Results of a cohort single-center randomized study of the modulating effect of the drug Mexidol in the rehabilitation of patients who suffered acute cerebral insufficiency. S.S. Korsakov Journal of Neurology and Psychiatry. 2024;(4):108-117

Cognitive impairment in patients with arterial hypertension. S.S. Korsakov Journal of Neurology and Psychiatry. 2024;(4-2):41-48

Study of the practice of prescribing phenosanic acid in epilepsy accompanied by asthenic disorders. S.S. Korsakov Journal of Neurology and Psychiatry. 2024;(7):89-97

Place of oligopeptide H-Met-Glu-His-Phe-Pro-Gly-Pro-OH in the therapy and rehabilitation of patients with ischemic stroke. S.S. Korsakov Journal of Neurology and Psychiatry. 2024;(8-2):56-63

The effect of ethylmethylhydroxypyridine succinate on the parameters of chronic neuroinflammation and plastic processes in the brain of old rats during course of dexamethasone administration. S.S. Korsakov Journal of Neurology and Psychiatry. 2024;(9):115-121

Surgical treatment of congenital and acquired internal carotid artery tortuosity in patients with ocular ischemic syndrome. Russian Journal of Cardiology and Cardiovascular Surgery. 2024;(3):272-278

The role of mitochondrial dysfunction in the stabilization of the glaucomatous process. Russian Annals of Ophthalmology. 2024;(4):49-58

Possibilities of using cytoprotectors in complex therapy of chronic coronary heart disease. Russian Journal of Cardiology and Cardiovascular Surgery. 2024;(4):410-419

Determination of indications for antioxidant therapy at the stage of pregravidar preparation of patients with early fetal loss in anamnesis. Russian Bulletin of Obstetrician-Gynecologist. 2024;(5):66-70

The possibilities of Mexidol in the complex therapy of arterial hypertension. Russian Journal of Cardiology and Cardiovascular Surgery. 2024;(5):572-580

Forty patients, aged from 55 to 74 years, with chronic cerebral ischemia - discirculatory encephalopathy, stages I-II, against the background of arterial hypertension and atherosclerosis were studied. Patients were randomized into 2 equal groups. Patients of the main group received the antioxidant mexidol intramuscular in dose 100 mg during the first 10 days and then perorally in dose 125 mg three times a day during 20 days in the combination with the regular treatment (diroton in dose 5-20 mg daily, cardiomagnyl in dose 75 mg daily). Patients of the control group received regular treatment during 30 days. The efficacy was evaluated at baseline, on the 10th and 30th days after the treatment using clinical scales (the number of complaints, neurological deficit, cognitive and emotional disorders), parameters of cerebral hemodynamics measured with transcranial duplex scanning, laboratory indices of the state of oxidant and antioxidant systems (the content of malonic dialdehyde and superoxide dismutase in the blood plasma as well as the plasma total antioxidant activity). The statistically significant (p<0.05-0.01) reduction in the severity of asthenic and anxiety disorders, the improvement of static-locomotor and cognitive functions as well as of parameters of cerebral hemodynamics due to the decrease in the peripheral vascular resistance and the normalization of venous outflow from the cavity of scull was seen in patients treated with mexidol compared to the baseline and the control group. Mexidol significantly reduced the intensity of lipid peroxidation and increase the total antioxidant activity of the blood. The results obtained in the study allow to consider mexidol as the effective drug in the complex treatment of discirculatory encephalopathy in elderly patients.

Authors:

Abramenko Yu.V.

Tver State Medical University, Tver, Russia

List of references:

Bleikher V.M., Kruk I.V., Bokov S.N. Metodiki dlya issledovaniya vnimaniya i psikhomotornykh reaktsii. Klinicheskaya patopsikhologiya. M 2002; 57-69.
Vein A.M. i dr. Depressiya v nevrologicheskoi praktike (klinika, diagnostika, lechenie). M: MIA 2002; 155.
Vertkin A.L., Donchinova A.A., Naumov A.V., Skorikova Yu.S. Sistema koordinat dlya vybora neiroprotektivnoi terapii. RMZh 2007; 15: 16: 1211-1216.
Voronina T.A., Smirnov L.D., Goryainova I.I. Mekhanizm deistviya i obosnovanie primeneniya preparata meksidol v nevrologii. M 2002; 14.
Gusev E.I., Skvortsova V.I. Khronicheskaya ishemiya mozga. M: Meditsina 2003; 318.
Damulin I.V., Parfenov V.A., Skoromets A.A., Yakhno N.N. Narusheniya krovoobrashcheniya v golovnom i spinnom mozge. Bolezni nervnoi sistemy: Rukovodstvo dlya vrachei. V 2 t. T. 1. Pod red. N.N. Yakhno, D.R. Shtul'mana. 2-e izd., pererab. i dop. M: Meditsina 2001; 231-302.
Korobeinikova E.N. Modifikatsiya opredeleniya produktov perekisnogo okisleniya lipidov v reaktsii s tiobarbiturovoi kislotoi. Lab delo 1989; 7: 8-9.
Kryzhanovskii G.N. Obshchaya patofiziologiya nervnoi sistemy. M 1997; 352.
Lavrov A.Yu., Yakhno N.N., Buziashvili Yu.I., Shumilina M.V. Kharakteristika arterial'noi i venoznoi tserebral'noi gemodinamiki na raznykh stadiyakh distsirkulyatornoi entsefalopatii. Prilozhenie "Insul't". Zhurn nevrol i psikhiat 2005; 15: 4-12.
Levin O.S. Distsirkulyatornaya entsefalopatiya: sovremennye predstavleniya o mekhanizmakh razvitiya i lechenii. M: Serv'e 2006; 24.
Levin O.S., Yunishchenko N.A. Diagnostika i lechenie kognitivnykh narushenii pri distsirkulyatornoi entsefalopatii. Consilium Medicum 2008; 9: 8: 47-52.
Levin O.S. Diagnostika i lechenie dementsii v klinicheskoi praktike. MEDpress-inform 2010; 256.
Lelyuk V.G., Lelyuk S.E. Ul'trazvukovaya angiologiya. 2-e izd., dopoln. i pererab. M: Real'noe vremya 2003; 336.
Leshchinskii L.D. Obosnovanie i opyt primeneniya ingibitorov perekisnogo okisleniya lipidov (POL) u bol'nykh ishemicheskoi bolezn'yu serdtsa. TOP-meditsina 1998; 4: 9-11.
Medvedeva L.A., Zagorul'ko O.I., Gnezdilov A.V. Neiroprotektivnaya korrektsiya paroksizmal'nykh rasstroistv pri vegetososudistoi distonii. M 2006; 23.
Mit'kov V.V. Klinicheskoe rukovodstvo po ul'trazvukovoi diagnostike. M 1999; 4: 211-212, 274.
Odinak M.M., Voznyuk N.A. Meksidol v lechenii ostroi i khronicheskoi ishemii golovnogo mozga. Vestn praktich nevrol 2003; 7: 21-26.
Rumyantseva S.A., Kravchuk A.A., Silina E.V. Antioksidanty v terapii tserebrovaskulyarnykh zabolevanii. Lechashchii vrach 2006; 5: 42-47.
Semchenko L.N., Drozdova T.V., Zinov'eva M.N. Primenenie preparata meksidol dlya lecheniya bol'nykh s khronicheskoi tserebrovaskulyarnoi nedostatochnost'yu s vestibulokokhlearnymi proyavleniyami. Prilozhenie 1. Byulleten' eksperimental'noi biologii i meditsiny 2006; 75-78.
Smirnova I.N., Fedorova T.N., Tanashyan M.M., Suslina Z.A. Klinicheskaya effektivnost' i antioksidantnaya aktivnost' meksidola pri khronicheskikh tserebrovaskulyarnykh zabolevaniyakh. Atmosfera. Nervnye bolezni 2006; 1: 33-36.
Stakhovskaya L.V., Gudkova V.V. Mesto distsirkulyatornoi entsefalopatii v strukture tserebrovaskulyarnykh zabolevanii. Voprosy diagnostiki i lecheniya. Prilozhenie k zhurnalu Consilium medicum. Nevrologiya 2009; 2: 28-34.
Suslina Z.A., Smirnova I.N., Tanashyan M.M. i dr. Meksidol pri khronicheskikh formakh tserebrovaskulyarnykh zabolevanii. Lechenie nervnykh boleznei 2002; 3: 28-33.
Tupeev I.R., Kryzhanovskii G.N., Nikushkin E.V. i dr. Antioksidantnaya sistema v dinamike kompleksnogo lecheniya bol'nykh epilepsiei traditsionnymi protivosudorozhnymi preparatami i antioksidantom - al'fa-tokoferolom. Byulleten' eksperimental'noi biologii i meditsiny 1993; 10: 362-364.
Fedin A.I. Oksidantnyi stress i primenenie antioksidantov v nevrologii. Atmosfera. Nervnye bolezni 2002; 1: 15-18.
Fedin A.I., Rumyantseva S.A. Intensivnaya terapiya ishemicheskogo insul'ta. M: Med kniga 2004; 284.
Shalashova M.L., Dudaeva N.G., Golovacheva T.V. Primenenie meksidola v kombinirovannoi terapii s traditsionnymi antigipertenzivnymi sredstvami u bol'nykh arterial'noi gipertenziei s priznakami khronicheskoi tserebral'no-sosudistoi nedostatochnosti. Prilozhenie 1. Byulleten' eksperimental'noi biologii i meditsiny 2006; 152-156.
Shanin Yu.N. i dr. Antioksidantnaya terapiya v klinicheskoi praktike. St-Peterburg: Izd-vo ELBI 2003; 121.
Shetekauri S.A. Sovremennye vozmozhnosti antioksidantnoi terapii i opyt lecheniya meksidolom khronicheskoi tserebrovaskulyarnoi nedostatochnosti. Prilozhenie 1. Byulleten' eksperimental'noi biologii i meditsiny 2006; 156-159.
Shumilina M.V. i dr. Disbalans venoznogo tserebral'nogo krovoobrashcheniya v geneze entsefalopatii u bol'nykh s serdechno-sosudistymi zabolevaniyami. Annaly khir 2001; 4: 62-67.
Yakhno N.N., Damulin I.V., Zakharov V.V. i dr. Primenenie tanakana pri nachal'nykh stadiyakh sosudistoi mozgovoi nedostatochnosti: rezul'taty otkrytogo mnogotsentrovogo issledovaniya. Nevrologicheskii zhurn 1998; 3: 6: 18-22.
Yakhno N.N., Damulin I.V., Zakharov V.V. Distsirkulyatornaya entsefalopatiya. M 2000; 32.
Beck A.T. et al. An inventory for measuring depression. Arch Gen Psichiat 1961; 5: 561-571.
Denckla M.B. Revised neurological examination for subtle signs. Psychopharm Bull 1985; 21: 773-789.
Dubois V., Slachevsky A., Litvan I., Pillon B. The FAB: a frontal assessment battery at bedside. Neurology 2000; 55: 1621-1626.
Folstein M.F., Filstein S.E., McHugh P.R. Mini-Mental State: a practical guide for grading the mental state of patients for the clinician. J Psychiat Res 1975; 12: 189-198.
Guy W., Bonato R. CGI - Clinical Global Impressions Manual for the ECDEU Assessment Battery 2 Rev. National Institute of Menthal Health. Ed. Chevy Chase. Maryland 1976; 12: 1-6.
Lipton R. Ischemic Cell Death in Brain Neurons. Physiological Reviews 1999; 79: 1431-1568.
Manno E.M., Atkinson J.L., Fulgham J.R. et al. Emerging medical and surgical management strategies in the evaluation and treatment of intracerebral hemorrhage. Mayo Clin Proc 2005; 80: 420-433.
Spilberger S.D. et al. Manual for the State-Trait Anxiety Inventory. Palo Alto 1970; 38.
Tinnetti M.E. Performance-oriented assessment of mobility problems in elderly patients. J Am Geriat Soc 1986; 34: 119-126.

Close metadata